TRITERPEN-AMIN-DERIVATE
European patent · EP3796900 · In force
Register entry
- Publication number
- EP3796900
- Application number
- EP19827166
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 28, 2019
- Published
- Mar 31, 2021
- Granted
- Apr 8, 2026
- Protection ends at the latest
- Jun 27, 2039
- Next annual fee due
- Jun 30, 2026
- IPC classes
- C07J 63/00 (2006.01)A61K 31/185 (2006.01)A61K 31/195 (2006.01)A61K 31/58 (2006.01)C07J 53/00 (2006.01)A61K 31/575 (2006.01)A61K 31/06 (2006.01)A61P 31/18 (2006.01)A61K 45/06 (2006.01)
- Priority
- US 201862692071 P 29.06.2018
- PCT application
- PCT/US2019/039981 28.06.2019
- PCT publication
- WO2020/006510 02.01.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 8, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 08.04.2026
Parties
Holder
19008 Oxcart Place, Gaithersburg, Maryland 20886, US
The United States of America, as represented by The Secretary, Department of Health and Human Services
National Institute of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325, Msc 7660, Bethesda, MD 20852-7660, US
Inventor
Boyds Maryland 20841, US
Gaithersburg Maryland 20886, US
Shawnee Oklahoma 74801, US
Frederick Maryland 21702, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.